Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$19.86 USD
-0.20 (-1.00%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $19.84 -0.02 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Castle Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -57.47 | -67.14 | -31.29 | -10.28 | 5.28 |
Depreciation/Amortization & Depletion | 6.84 | 9.18 | 3.41 | 1.31 | 2.28 |
Net Change from Assets/Liabilities | -6.63 | -0.01 | -4.10 | 9.15 | 0.04 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 51.63 | 16.32 | 13.00 | 9.69 | -0.59 |
Net Cash From Operating Activities | -5.63 | -41.66 | -18.98 | 9.87 | 7.02 |
Property & Equipment | -13.61 | -5.44 | -3.47 | -4.75 | -0.94 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -26.42 | -63.18 | 0.00 | 0.00 |
Investments | -2.57 | -134.69 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -16.18 | -166.55 | -66.66 | -4.75 | -0.94 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.98 | 3.33 | 6.55 | 333.25 | 76.61 |
Issuance (Repayment) of Debt | -0.14 | -0.12 | 0.00 | -27.36 | 11.68 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -5.13 | -1.69 | -1.12 | 0.00 | 0.00 |
Net Cash from Financing Activities | -2.30 | 1.52 | 5.42 | 305.89 | 88.29 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -24.11 | -206.69 | -80.22 | 311.01 | 94.37 |
Cash at Beginning of Period | 122.95 | 329.63 | 409.85 | 98.85 | 4.48 |
Cash at End of Period | 98.84 | 122.95 | 329.63 | 409.85 | 98.85 |
Diluted Net EPS | -2.14 | -2.58 | -1.24 | -0.54 | -0.21 |
Fiscal Year End for Castle Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -57.47 | -54.89 | -47.98 | -29.20 |
Depreciation/Amortization & Depletion | NA | 6.84 | 5.26 | 3.65 | 1.66 |
Net Change from Assets/Liabilities | NA | -6.63 | -14.30 | -11.49 | -11.65 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 51.63 | 39.71 | 26.60 | 13.75 |
Net Cash From Operating Activities | NA | -5.63 | -24.21 | -29.23 | -25.44 |
Property & Equipment | NA | -13.61 | -9.82 | -7.37 | -3.33 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -2.57 | 1.31 | 8.56 | 19.92 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -16.18 | -8.51 | 1.20 | 16.58 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 2.98 | 2.22 | 1.87 | 1.08 |
Issuance (Repayment) of Debt | NA | -0.14 | -0.11 | -0.07 | -0.04 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -5.13 | -1.12 | -0.85 | -0.31 |
Net Cash from Financing Activities | NA | -2.30 | 1.00 | 0.95 | 0.73 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -24.11 | -31.73 | -27.07 | -8.13 |
Cash at Beginning of Period | NA | 122.95 | 122.95 | 122.95 | 122.95 |
Cash at End of Period | NA | 98.84 | 91.22 | 95.87 | 114.82 |
Diluted Net EPS | NA | -0.08 | -0.26 | -0.70 | -1.10 |